|
Delayed
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 3.080 USD | +0.98% |
|
-1.91% | -9.68% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Company Valuation: LifeMD, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 118.4 | 61.01 | 325 | 214.4 | 164.1 | 148.5 | - | - |
| Change | - | -48.47% | 432.67% | -34.03% | -23.44% | -9.56% | - | - |
| Enterprise Value (EV) | 77.74 | 61.01 | 325 | 214.4 | 164.1 | 148.5 | 148.5 | 148.5 |
| Change | - | -21.52% | 432.67% | -34.03% | -23.44% | -9.56% | 0% | 0% |
| P/E | -1.69x | -1.24x | -11.8x | -9.34x | -19.5x | -5.94x | -58.3x | 16.6x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.2x | 0.4x | 0.3x | -0x | 0.6x | -0x |
| Capitalization / Revenue | 1.27x | 0.51x | 2.13x | 1.01x | 0.85x | 0.72x | 0.61x | 0.53x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.72x | 0.61x | 0.53x |
| EV / EBITDA | -0x | -0x | 0x | 0x | 0x | -41.1x | 6.94x | 4.16x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -6.82x | 134x | 9.89x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.29 | -1.57 | -0.7 | -0.53 | -0.1753 | -0.5186 | -0.0529 | 0.185 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 92.88 | 119 | 152.5 | 212.5 | 194.1 | 207.5 | 245 | 280.3 |
| EBITDA 1 | -38.28 | -14.66 | 11.98 | 14.38 | 15.25 | -3.614 | 21.39 | 35.72 |
| EBIT 1 | -54.3 | -43.45 | -14.49 | -16.14 | -7.67 | -21.77 | 1.107 | 15.02 |
| Net income 1 | -61.77 | -48.64 | -23.7 | -21.99 | -7.913 | -24.83 | -2.675 | 9.405 |
| Net Debt | -40.66 | - | - | - | - | - | - | - |
| Reference price 2 | 3.870 | 1.940 | 8.290 | 4.950 | 3.410 | 3.080 | 3.080 | 3.080 |
| Nbr of stocks (in thousands) | 30,593 | 31,450 | 39,203 | 43,312 | 48,136 | 48,201 | - | - |
| Announcement Date | 3/7/22 | 3/22/23 | 3/11/24 | 3/10/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.94x | - | - | - | 148M | |
| 42.12x | 10.16x | 22.39x | -.--% | 44.54B | |
| 97.03x | 52.79x | 67.03x | 0.54% | 13.1B | |
| 75.23x | 12.87x | 51.87x | 0.55% | 5.85B | |
| -58.05x | 16.45x | -107.72x | - | 4.25B | |
| -7.03x | 62.88x | -7.13x | - | 2.1B | |
| 34.95x | - | - | -.--% | 1.57B | |
| -129.52x | - | - | - | 1.1B | |
| 6.94x | - | - | - | 1.02B | |
| Average | 6.19x | 31.03x | 5.29x | 0.27% | 8.19B | |
| Weighted average by Cap. | 44.03x | 20.35x | 24.42x | 0.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LFMD Stock
- Valuation LifeMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
